Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 5,328

Document Document Title
WO/2022/163708A1
Provided is a fluorine-containing ether compound represented by the following formula. R1-R2-CH2-R3-CH2-R4 (wherein R1 is a terminal group that includes an oxime group and is represented by formula (2), R2 is a divalent linking...  
WO/2022/158993A1
The present invention relates to a method for the production of d-erythro-sphingosine and analogs thereof, wherein the method comprises a step of condensing a compound of formula (2): Formula (2), or a salt thereof, wherein R1 is hydroge...  
WO/2022/149459A1
A non-linear optical absorption material according to an aspect of the present disclosure contains, as a main component, a compound represented by formula (1). In formula (1), R1 to R27 contain, independently of each other, at least one ...  
WO/2022/149460A1
A light-absorbing material in one embodiment of the present disclosure contains, as a main component, the compound represented by formula 1 below. In formula 1, R1 through R28 contain, independently from one another, at least one atom se...  
WO/2022/138478A1
Provided is a fluorine-containing ether compound represented by the following formula. R1-R2-CH2-R3-CH2-R4-R5 (R1 and R5 each represent a terminal group represented by formula (2) and including an oxime group, R2 and R4 each represent a ...  
WO/2022/126942A1
The present invention relates to the field of synthesis and preparation of medical intermediates. Disclosed is a synthesis method for a medical intermediate cyclopropyl-containing chiral amine hydrochloride. According to the present inve...  
WO/2022/110930A1
The present invention provides a method for ammoximation of macrocycloalkanone, comprising the following steps: adding hydrogen peroxide, ammonia water, a hydroxylamine stabilizer, an oximation catalyst, a solvent, and a macrocycloalkano...  
WO/2022/084254A1
The present invention describes a mixture of isomeric aldimines of the formulae (Ia), (Ib) and (Ic) in which the ratio of the trans,trans isomer (Ia) to the sum of the cis,trans isomer (Ib) and the cis,cis isomer (Ic) is in the range of ...  
WO/2022/084252A1
The present invention describes a moisture-curing polyurethane composition comprising – at least one isocyanate-functional polymer with a content of monomeric isophorone diisocyanate of below 0.5 weight-%, obtained from the reaction of...  
WO/2022/073525A1
A method and device for integrating an ammoximation reaction and separation. In the method, titanium-silicon molecular sieve is used as a catalyst; an ammoximation reaction of a ketone, hydrogen peroxide and ammonia is carried out to gen...  
WO/2022/069553A1
The invention relates to a method for producing benzaldehyde oximes of the general formula (I) and to the use thereof as important precursors for the synthesis of agrochemical and pharmaceutical active substances.  
WO/2022/063351A1
The subject of the invention is azulene hydrazide-hydrazones bearing 2-hydroxyaryl group of general formula I. These compounds show selective cytostatic effect and therefore they can be used for the preparation of medicaments for the tre...  
WO/2022/064454A1
The present invention discloses a process for the synthesis of compound of formula (VII) or a salt thereof, wherein, R, R1, R2, R3, R4a and R4b are as defined in the detailed description. The process further comprises the synthesis of an...  
WO/2022/058580A1
Compounds of the formula (I) wherein the substituents are as defined in claim 1, useful as a pesticides, especially as fungicides.  
WO/2022/046676A1
Hemorrhage and vascular instability can be induced by thrombolytic and anti-coagulant therapies. Presented herein, in certain aspects, are methods for the treatment and/or prevention of hemorrhage and vascular instability that comprise a...  
WO/2022/037525A1
Disclosed are an acetophenone oxime compound and a preparation method therefor, and specifically disclosed are a compound as shown in formula (II) and a pharmaceutically acceptable salt thereof.  
WO/2022/034426A1
The present invention relates to a process for the preparation of a key intermediate and other intermediates useful for the synthesis of Siponimod, a drug used for the treatment of multiple sclerosis. Object of the invention are also sai...  
WO/2022/013009A1
The present invention relates to the use of strobilurin type compounds of formula (I) and the N-oxides and the salts thereof for combating phytopathogenic fungi containing an amino acid substitution F129L in the mitochondrial cytochrome ...  
WO/2022/008303A1
The present invention relates to the use of strobilurin type compounds of formula (I) and the N-oxides and the salts thereof for combating phytopathogenic fungi containing an amino acid substitution F129L in the mitochondrial cytochrome ...  
WO/2022/002567A1
Imine, obtainable by reacting (i) an amino-functionalized polyoxyalkylene, the polyoxyalkylene chains being a copolymer that consists of oxyethylene- and oxypropylene units, and these polyoxyalkylene chains carry (preferably per molecule...  
WO/2021/249928A1
The present invention relates to the use of strobilurin type compounds of formula I and the N-oxides and the salts thereof for combating phytopathogenic fungi containing an amino acid substitution F129L in the mitochondrial cytochrome b ...  
WO/2021/239568A1
The present invention relates to a process for the preparation of substituted 4-(N'-hydroxy- carbamimidoyl)benzoic acids, which can be obtained by nitrilase catalyzed hydration of substituted terephthalonitriles of formula (II) in an aqu...  
WO/2021/235164A1
A linear optical material according to an aspect of the present disclosure is represented by formula (1). At least one selected from the group consisting of R1 to R5, at least one selected from the group consisting of R6 to R10, and at l...  
WO/2021/235165A1
A nonlinear optical material according to one aspect of the present invention is represented by formula (1).  
WO/2021/227206A1
Disclosed are a diethylamine-containing azine hydrazine compound, a preparation method therefor and an application thereof. The method comprises: performing a heating reaction on a diphenylhydrazine derivative and a diethylamine-containi...  
WO/2021/225982A1
Disclosed herein are small molecule SOS1 allosteric site inhibitors, pharmaceutical compositions, and methods of use thereof.  
WO/2021/212460A1
Disclosed by the present application is a method for autocatalytic preparation of 2,5-furandicarboxaldehyde oxime. The method for the autocatalytic preparation of the 2,5-furandicarboxaldehyde oxime comprises: reacting 2,5-furandicarboxa...  
WO/2021/208201A1
The present invention provides an external micro-interface ammoximation reaction system and method. The external micro-interface ammoximation reaction system comprises an oximation reactor, a reaction clear liquid buffer tank, a tert-but...  
WO/2021/208199A1
The present invention provides a reaction system and method for ammoximation and tert-butyl alcohol recovery. The reaction system comprises an oximation reactor, a reaction clear liquid buffer tank, a tail gas absorption tower, a tert-bu...  
WO/2021/208200A1
The present invention provides a built-in micro-interface ammoximation reaction system and method, the system comprising an oximation reactor, a reaction supernatant buffer tank, a tert-butanol recovery tower, an extraction tank, a water...  
WO/2021/190567A1
Disclosed in the present invention are a diphenyl sulfide ketone oxime ester compound, a preparation method therefor, a composition and use thereof. A diphenyl sulfide ketone oxime ester photoinitiator has the characteristics of high sen...  
WO/2021/177359A1
This ammonia decomposition method is a method for obtaining nitrogen, protons, and electrons by oxidative decomposition of ammonia in the presence of a base, using as a catalyst a salen-manganese complex in which manganese is used as a b...  
WO/2021/175886A1
The present invention relates to a fusing agent, comprising a compound of formula (I), a three-dimensional (3D) printing kit including the compound of formula (I) and A method for three-dimensional (3D) printing, including selectively ap...  
WO/2021/168582A1
The present invention generally relates to a chemical process under flow conditions for manufacturing compounds which absorb ultraviolet (UV) radiation and protect biological materials as well as non-biological materials from damaging ex...  
WO/2021/158046A1
The present invention relates to a pharmaceutical composition comprising gossypol or a derivative thereof as an active ingredient for prevention or treatment of a neurological disorder. A decrease in the level of the inhibitory neurotran...  
WO/2021/153786A1
The present invention provides a compound having an excellent control effect against pests. A compound represented by formula (1) of the present invention (in the formula, Q represents a group indicated by Q1 or a group indicated by Q2 (...  
WO/2021/153794A1
The present invention provides a method of controlling soybean rust fungus that has an F129L amino acid substitution in the mitochondrial cytochrome b protein. The compound represented by formula (I) can be used to control soybean rust f...  
WO/2021/148426A1
The present invention relates to compounds of formula (I) as defined herein. The compounds are suitable for protection against ultraviolet (UV) radiation. Further, the present invention is concerned with compositions comprising at least ...  
WO/2021/122594A1
The present invention relates to compounds having one of the following formulae (I) or (II): (I) (II), and to uses thereof.  
WO/2021/096811A1
Disclosed herein are tucaresol derivative compound and composition containing the same. Also disclosed herein are methods of enhancing immune response in a subject by administering the tucaresol derivative compound or by co-administering...  
WO/2021/081677A1
Provided are compounds and salts having a structure of Formula (I) or (II): (I), and (II) wherein: both of the chiral carbon atoms denoted by "*" are both in the R configuration or both in the S configuration. Compounds and salts of Form...  
WO/2021/082278A1
Disclosed are a class of fluorine-containing α-diimine nickel complexes for preparing a polyolefin elastomer and intermediates thereof. The class of complexes have a single catalytic active center, the molecular weight of a polymer can ...  
WO/2021/081624A1
The use of glutamate 2b receptor antagonists and sigma receptor agonists as antitussives to treat or prevent a cough is disclosed. In preferred embodiments, the glutamate 2b receptor antagonist is ifenprodil or radiprodil. Preferred sigm...  
WO/2021/031984A1
Disclosed are a carboxylic acid oxime ester compound and the use thereof as a herbicide and for preparing a microbicide. The carboxylic acid oxime ester compound is as represented by general formula I:  
WO/2021/035176A1
The invention provides a compound of formula (I): wherein R1, R2, and R3 have any of the values described in the specification, as well as compositions comprising a compound of formula (I), methods for preparing compounds of formula (I),...  
WO/2021/023144A1
Disclosed in the present invention is a novel fluorenoxime ester compound, a preparation method therefor, a photoinitiator containing the fluorenoxime ester compound, and a photosensitive resin composition. The fluorenoxime ester compoun...  
WO/2021/009026A1
Compounds of formula (I): (Formula (I)) Formula (I) encompasses e.g. tetraline, chromane, isochromane, 6,7,8,9-tetrahydrobenzo[7]annulene, 1H-isobenzofurane and indane derivatives. The compounds of formula (I) are useful as a pesticides,...  
WO/2020/262648A1
The present invention provides a compound that has an excellent pest-controlling effect and that is represented by formula (I) [in the formula, L represents an oxygen atom or CH2, E represents a C2-C10 chain hydrocarbon group or the like...  
WO/2020/258971A1
Provided are a new class of hydrazone amide derivatives and the use thereof in the preparation of anti-osteoporosis drugs, wherein the structural formula of the hydrazone amide derivative is as shown in formula (I), and same are a new cl...  
WO/2020/245468A1
The present invention relates to compounds useful as modulators of sirtuins, in particular as activators of SIRT1. Furthermore, the invention refers to the medical use of such compounds, in particular in the prevention and/or treatment o...  

Matches 1 - 50 out of 5,328